Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by robertshawon May 26, 2017 4:27pm
155 Views
Post# 26290362

RE:RE:NBC DFW

RE:RE:NBC DFW
skier59 wrote: Just got home about 30 minutes ago and this one sums it up best as I'm reading through 7 pages of posts. To us longs that truly understand this whole story, today's NR was exactly what I was waiting for before I added to my position and I did. This morning at the open I added 14500 @50 and just now I added another 15500 @ 475. Basically I sold everything in my TFSA and loaded up TLT which now stands at 90,000 shares in my TFSA + a small bunch in my RRSP. So I am finally holding in the 6 figure club and very happy to be in that position :) I'm not totally surprised that we haven't moved up, mostly because I'm expecting a PP which will probably come in around this level. I've been hoping it might be delayed, but my gut feeling watching the trading in the past few weeks is that it has already been negotiated and established. Like I said, to me, this first step was EXTREMELY IMPORTANT and I really don't care what I paid for these shares, I was prepared to pay 80 cents. Now I can sit back and relax and let the company and the good doctors do their stuff and I don't have to worry about NOTHING !

harpos wrote: The new investors will wait for the splashy efficacy nr. To those of us that follow this closely, safety and tolerability was everything. Photofrin killed cancer 19 years ago. This patented compound has preclinically tested to be 198 more potent than Photofrin. This company was derisked today. This dose killed 98 percent of the cancer in rats. IMO, the worst that could happen now is we have to go back to this dose if the double dose causes problems. There is no significant damage to the bladder or even an in continence problem or they would not be going forward with a double dose and six new patients. This means everything for us. Those short s are very lucky to be getting out. Everybody, myself included can  just sit back and let the good times roll. 
It is amazing news. You may not see RW trumpet the the cancer kill at all until the poison pill is in place. Big pharma would have no choice but to take it t out of his hands if it was obvious that their billion dollar drugs were going to get left on the shelf. This is why Dr. Jewitt emphasized "small Canadian company" because it is evident how remarkable this accomplishment is and how it puts Theralase ahead of the big boys.




Congratulations to your over 100k+ shares holding. I am still on my way of accumulating to the agreement numbers with Bunge, besides I have a coworker who has 372k shares 2 months ago... Stay strong, good luck for us all.
Bullboard Posts